Breast Cancer Clinical Trial
Official title:
Comparison of Single Versus Double Drains After Modified Radical Mastectomy
It is not known whether decreasing the number of drains used decreases patients' discomfort
and duration of hospital stay without increasing seroma formation after mastectomies.
Hypothesis. Use of one drain increases patient comfort without increasing seroma formation
after modified radical mastectomy (MRM) as compared to double drains.
Material and Method: Sixty patients undergoing MRM at Diskapi Yildirim Beyazit Training and
Research Hospital will be randomised into single versus double drains groups. A negative
pressure drain will be inserted below the lower flap directing to the axilla in the single
drain group or two similar drains will be inserted into the axilla and below the lower flap
in the double drains group. Drains will be removed if the output is less than 30 ml. Seroma
is defined as fluid accumulation below the flaps and will be examined daily after the
operation. One day after removal of the drains seroma under the flaps and in the axilla will
be examined by ultrasonography. Age, body mass index smoking history, coexisting diseases of
the patients duration of the hospital stay, duration of the drains in place, total drain
output in the first three days after the operation and the need and frequency of aspirations
due to seroma formation will be recorded. Patient comfort was measured with a comfort scale
between 1-10 measuring incisional pain, pain caused by the drains, discomfort or sleep
disturbances caused by the drains, The duration of the longer staying drain in the double
drain group will be recorded for the duration of the drain in place parameter.
Background: Seroma is one of the most common complications after mastectomies. Seroma
formation results in delays in wound healing, incisional dehiscence, infections and long
hospital stay. Although there are studies proving that drains do not prevent seroma
formation, the use of drains for that purpose is still very common. Decreasing the number of
drains used after mastectomies has been shown to decrease patients' discomfort and duration
of hospital stay without increasing seroma formation.
Objective: To investigate the effects of single versus double drains on patient comfort and
seroma formation after modified radical mastectomy (MRM) Material and Method: Sixty patients
undergoing MRM at Diskapi Yildirim Beyazit Training and Research Hospital will be randomised
into single versus double drains groups. A negative pressure drain will be inserted below
the lower flap directing to the axilla in the single drain group or two similar drains will
be inserted into the axilla and below the lower flap in the double drains group. Drains will
be removed if the output is less than 30 ml. Seroma is defined as fluid accumulation below
the flaps and will be examined daily after the operation. One day after removal of the
drains seroma under the flaps and in the axilla will be examined by ultrasonography. Age,
body mass index smoking history, coexisting diseases of the patients duration of the
hospital stay, duration of the drains in place, total drain output in the first three days
after the operation and the need and frequency of aspirations due to seroma formation will
be recorded. Patient comfort was measured with a comfort scale between 1-10 measuring
incisional pain, pain caused by the drains, discomfort or sleep disturbances caused by the
drains, The duration of the longer staying drain in the double drain group will be recorded
for the duration of the drain in place parameter. Two groups will be compared with
chi-square, student's t-test or Mann-Whitney U test. P<0.005 will be considered as
significant.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |